» Articles » PMID: 25528462

Use of a Continuous Twin Screw Granulation and Drying System During Formulation Development and Process Optimization

Overview
Specialty Pharmacology
Date 2014 Dec 22
PMID 25528462
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Since small scale is key for successful introduction of continuous techniques in the pharmaceutical industry to allow its use during formulation development and process optimization, it is essential to determine whether the product quality is similar when small quantities of materials are processed compared to the continuous processing of larger quantities. Therefore, the aim of this study was to investigate whether material processed in a single cell of the six-segmented fluid bed dryer of the ConsiGma™-25 system (a continuous twin screw granulation and drying system introduced by GEA Pharma Systems, Collette™, Wommelgem, Belgium) is predictive of granule and tablet quality during full-scale manufacturing when all drying cells are filled. Furthermore, the performance of the ConsiGma™-1 system (a mobile laboratory unit) was evaluated and compared to the ConsiGma™-25 system. A premix of two active ingredients, powdered cellulose, maize starch, pregelatinized starch and sodium starch glycolate was granulated with distilled water. After drying and milling (1000 μm, 800 rpm), granules were blended with magnesium stearate and compressed using a Modul™ P tablet press (tablet weight: 430 mg, main compression force: 12 kN). Single cell experiments using the ConsiGma™-25 system and ConsiGma™-1 system were performed in triplicate. Additionally, a 1h continuous run using the ConsiGma™-25 system was executed. Process outcomes (torque, barrel wall temperature, product temperature during drying) and granule (residual moisture content, particle size distribution, bulk and tapped density, hausner ratio, friability) as well as tablet (hardness, friability, disintegration time and dissolution) quality attributes were evaluated. By performing a 1h continuous run, it was detected that a stabilization period was needed for torque and barrel wall temperature due to initial layering of the screws and the screw chamber walls with material. Consequently, slightly deviating granule and tablet quality attributes were obtained during the start-up phase of the 1h run. For the single cell runs, granule and tablet properties were comparable with results obtained during the second part of the 1h run (after start-up). Although deviating granule quality (particle size distribution and Hausner ratio) was observed due to the divergent design of the ConsiGma™-1 unit and the ConsiGma™-25 system (horizontal set-up) used in this study, tablet quality produced from granules processed with the ConsiGma™-1 system was predictive for tablet quality obtained during continuous production using the ConsiGma™-25 system.

Citing Articles

Systematic investigation of the impact of screw elements in continuous wet granulation.

Kiricenko K, Meier R, Kleinebudde P Int J Pharm X. 2024; 8:100273.

PMID: 39206252 PMC: 11357779. DOI: 10.1016/j.ijpx.2024.100273.


An Advanced Twin-Screw Granulation Technology: The use of Non-Volatile Solvents with High Solubilizing Capacity.

Kolipaka S, Junqueira L, Ross S, Garg V, Mithu M, Bhatt S AAPS PharmSciTech. 2024; 25(6):174.

PMID: 39085532 DOI: 10.1208/s12249-024-02890-y.


Optimizing Energy Efficiency of a Twin-Screw Granulation Process in Real-Time Using a Long Short-Term Memory (LSTM) Network.

Sampat C, Ramachandran R ACS Eng Au. 2024; 4(2):278-289.

PMID: 38646515 PMC: 11027094. DOI: 10.1021/acsengineeringau.3c00038.


Application of I-Optimal Design for Modeling and Optimizing the Operational Parameters of Ibuprofen Granules in Continuous Twin-Screw Wet Granulation.

Zhao J, Tian G, Qu H Biomedicines. 2023; 11(7).

PMID: 37509668 PMC: 10377492. DOI: 10.3390/biomedicines11072030.


Pharmaceutical Application of Process Understanding and Optimization Techniques: A Review on the Continuous Twin-Screw Wet Granulation.

Zhao J, Tian G, Qu H Biomedicines. 2023; 11(7).

PMID: 37509561 PMC: 10377609. DOI: 10.3390/biomedicines11071923.